You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Combined Immune Deficiency (CID) syndromes

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Development of Minimally Invasive Methodology for Diabetyping to

Not yet recruiting
  • Type 2 Diabetes
    • (no location specified)
    Nov 3, 2023

    Mild Cognitive Impairment, MDD, Recurrent, In Remission, MDD, Single Episode, in Full Remission Trial in Toronto (tDCS + CR,

    Active, not recruiting
    • Mild Cognitive Impairment
    • +2 more
    • tDCS + CR
    • sham tDCS + sham CR
    • Toronto, Ontario, Canada
    • +4 more
    Apr 20, 2021

    Genetic Factors of Desmopressin Response in Carriers of

    Completed
    • Carrier of Hemophilia A
    • +2 more
    • Bordeaux, France
    • +11 more
    Aug 28, 2023

    Dyspnea Trial in Paris (Auditive stimulation, Sensitive stimulation, Auditory control)

    Completed
    • Dyspnea
    • Auditive stimulation
    • +3 more
    • Paris, France
      Service de Pneumologie et Réanimation Médicale, Groupe Hospitali
    Sep 1, 2022

    Healthy Trial in Buenos Aires (RSVpreF+qIRV, qIRV, RSVpreF)

    Recruiting
    • Healthy
    • RSVpreF+qIRV
    • +3 more
    • Buenos Aires, Argentina
      Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
    Mar 27, 2023

    Real World Data on Ibrutinib Use in PCNSL Rel/Ref

    Recruiting
    • PCNSL
    • Milan, Italy
      Ospedale San Raffaele
    Mar 13, 2023

    Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Metastatic Cancer
    • (no location specified)
    Jan 11, 2022

    C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou, Guanzhou, Changsha (Hepatic Arterial Infusion

    Recruiting
    • C-staged Hepatocellular Carcinoma in BCLC Classification
    • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
    • Apatinib combined with Camrelizumab
    • Guangzhou, Guangdong, China
    • +4 more
    Jun 15, 2022

    Oral Cancer, Induction Chemo, Programmed Cell Death 1 Inhibitor Trial in Shanghai (drug, procedure, radiation)

    Active, not recruiting
    • Oral Cancer
    • +3 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
    Nov 17, 2021

    Osteoarthritis Trial in Kelowna (Autologous cell therapy)

    Recruiting
    • Osteoarthritis
    • Autologous cell therapy
    • Kelowna, British Columbia, Canada
      Pagdin Health
    Sep 8, 2021

    Kidney Transplant Trial in Atlanta (Living ACTS website, Standard transplant education procedures)

    Recruiting
    • Kidney Transplant
    • Living ACTS website
    • Standard transplant education procedures
    • Atlanta, Georgia
      Emory Transplant Center
    Apr 19, 2022

    Schizophrenia; Psychosis, Metabolic Syndrome, Flupentixol Trial in Taichung (Flupentixol, Multi-acting receptor-targeted

    Completed
    • Schizophrenia; Psychosis
    • +7 more
    • Flupentixol
    • Multi-acting receptor-targeted antipsychotics (MARTAs)
    • Taichung, Taiwan
      Taichung Veterans General Hospital
    May 20, 2021

    Facial Pain Trial in Sao Paulo (hyperbolid combined with tongue exercises on the palate, hyperbolid)

    Completed
    • Facial Pain
    • hyperbolid combined with tongue exercises on the palate
    • hyperbolid
    • Sao Paulo, Brazil
      University of Nove de Julho
    May 11, 2022

    HELLP Syndrome (HELLP), Third Trimester, Complement Abnormality, Morbidity;Newborn Trial in Baltimore (Eculizumab)

    Recruiting
    • HELLP Syndrome (HELLP), Third Trimester
    • +4 more
    • Baltimore, Maryland
      The Johns Hopkins University
    Jun 8, 2021

    Binge-Eating Disorder, Bulimia Nervosa, Veterans Health Trial in West Haven (Cognitive Behavioral Therapy (CBT))

    Recruiting
    • Binge-Eating Disorder
    • +3 more
    • Cognitive Behavioral Therapy (CBT)
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Aug 10, 2022

    Covid19 Trial in Graz (Omni-Biotic Pro Vi 5, Placebo)

    Active, not recruiting
    • Covid19
    • Omni-Biotic Pro Vi 5
    • Placebo
    • Graz, Austria
      Medical University Graz
    Sep 26, 2022

    Machine Learning Model for Beta-Lactam Drugs Related Acute

    Active, not recruiting
    • Acute Kidney Injury
    • Beta-Lactam Antibiotic Toxicity (Diagnosis)
    • Beta-Lactam Drugs
    • Jinan, Shandong, China
      Xiao Li，MD
    Sep 8, 2022

    PTSD, Chronic Pain Trial in Chicago (Stellate Ganglion Block Treatment, Placebo)

    Not yet recruiting
    • Posttraumatic Stress Disorder
    • Chronic Pain
    • Stellate Ganglion Block Treatment
    • Placebo
    • Chicago, Illinois
      Rush University Medical Center
    Sep 8, 2022

    Healthy Volunteers Trial in Limoges (Blood sample)

    Completed
    • Healthy Volunteers
    • Blood sample
    • Limoges, France
      Limoges University Hospital
    Oct 18, 2021

    Bullous Pemphigoid Trial in Sacramento (Rituximab combined with Omalizumab)

    Not yet recruiting
    • Bullous Pemphigoid
    • Rituximab combined with Omalizumab
    • Sacramento, California
      University of California, Davis, Department of Dermatology
    Aug 16, 2021

    NMO Spectrum Disorder, Azathioprine Adverse Reaction Trial in Nanning (Azathioprine)

    Completed
    • NMO Spectrum Disorder
    • Azathioprine Adverse Reaction
    • Nanning, Guangxi, China
      Qingmeng Huang
    Jun 8, 2023

    Speech Disorders, Voice Disorders, Parkinson Disease Trial (combined speech and music therapy, speech therapy, music therapy)

    Not yet recruiting
    • Speech Disorders
    • +2 more
    • combined speech and music therapy
    • +2 more
    • (no location specified)
    Jan 10, 2022

    Unresectable, Locally Advanced Or Metastatic Renal Cell

    Completed
    • Locally Advanced or Metastatic Renal Cell Carcinoma
    • Cabozantinib monotherapy
    • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
    • The Woodlands, Texas
      McKesson Life Sciences
    Nov 11, 2021

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Seattle

    Recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 10, 2022

    Metastatic Non Small Cell Lung Cancer Trial in Singapore (Nivolumab, ADG106)

    Recruiting
    • Metastatic Non Small Cell Lung Cancer
    • Singapore, Singapore
    • +1 more
    Mar 10, 2022